News

The next generation Watchman device is designed to better seal off complex LAA anatomy to prevent strokes in atrial fibrillation patients. It uses an optimized architecture to fill gaps and adapt to the unique characteristics of each patient's appendage, which come in a wide variety of shapes and sizes.
Next generation Watchman enters trial in 2026 as LAAO volume grows

The next generation Watchman device is designed to better seal off complex LAA anatomy in a variety of LAA shapes and sizes.

Thumbnail
ACC and AHA outline calculation of cost-effectiveness in clinical practice guidelines

Healthcare's cost-conscious environment prompted the ACC and AHA to develop a statement on the value methodology to be used when creating clinical practice guidelines.

The Artero peripheral electric IVL (E-IVL) system is about to enter its US FDA IDE trial.
FastWave lines up principal investigators for pivotal intravascular lithotripsy trial

"The key question isn't just whether a device works, but whether it makes procedures more efficient and provides physicians with a more predictable tool for treating patients with complex arterial disease," explained co-principal investigator Venita Chandra, MD, clinical professor of surgery at Stanford Health Care.

Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC, director of prevention, associate director, Barbra Streisand Women's Heart Center, Cedars-Sinai, and past president of the American Society for Preventive Cardiology (ASPC), was co-chair on a new joint scientific statement from the Heart Failure Society of America, and the ASPC on the need to boost prevention efforts for heart failure. She explains the new scientific statement that calls for greater prevention efforts in heart failure.
Putting more emphasis on prevention in heart failure care

Martha Gulati, MD, co-chair on a new joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology, discusses the dire need she sees to boost prevention efforts for heart failure.

 

SCAI outlines broken Medicaid reimbursement model for congenital heart disease

SCAI says many children and adults living with congenital heart disease are being left behind by a payment system that does not adequately value their care.

mammogram mammography breast cancer
AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

Vulnerable, but treatable: Semaglutide reduces symptoms in high-risk heart failure patients

Yes, even frail HFpEF patients see significant benefits when treated with semaglutide. Researchers believe these new data may help ease the minds of cardiologists everywhere.

Evinacumab-dgnb is sold by Regeneron under the brand name Evkeeza
FDA approves treatment of rare genetic disorder in children as young as 1 year old

Evinacumab-dgnb, sold by Regeneron under the brand name Evkeeza, can now be used to treat homozygous familial hypercholesterolemia in much younger patients.

As the national physician shortage deepens, cardiology is feeling the strain—especially in rural America. Recruitment challenges are growing, and health systems are grappling with how to attract and retain cardiologists in remote locations. Michelle Wimberly, director of physician recruitment and retention at Cardiovascular Logistics (CVL), says the solution starts with relationships and a commitment to long-term engagement.
How to bring cardiologists to rural America during a physician shortage

As the national physician shortage deepens, cardiology is feeling the strain. Recruiting cardiologists can be hard enough—bringing them to rural America is especially challenging due to the risk of isolation and other concerns.

Researchers using 4D MRI technology to test artificial hearts.
4D MRI techniques could help advance the development of artificial hearts

Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.

Surgeons Operating On Patient
TAVR reinterventions: What new data tell us about redo, explant trends over time

TAVR reintervention rates remain low. However, they are slowly rising as the procedure is used more to treat patients with severe aortic stenosis. Researchers think this trend may continue going forward.

Semaglutide tops dulaglutide when treating patients with type 2 diabetes and CVD

Researchers tracked real-world data from nearly 60,000 Medicare patients, highlighting the benefits of weekly injections of semaglutide. 

Around the web

Radiology Business
4D MRI techniques could help advance the development of artificial hearts

Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.

Health Exec
MGMA: Congress needs to act soon to preserve access to telemedicine programs

Congress needs to act soon to extend telemedicine services that were greatly expanded under COVID provisions, or they will expire by October. Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains concerns raised by doctors and lawmakers.

 

Health Exec
MGMA: Ending ACA subsidies could strain health system, leave millions uninsured

Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains the political and patient care issues involved with ending Affordable Care Act subsidies.